| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shilin Yang, Bing Yao, Yunfeng Zhou, Huiyong Yin, Ming-Zhi Zhang, Raymond C Harri. Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury. American journal of physiology. Renal physiology. vol 302. issue 6. 2012-05-09. PMID:22169008. |
the current studies investigated whether altering intrarenal dopamine levels affected ang ii-mediated renal fibrosis. |
2012-05-09 |
2023-08-12 |
mouse |
| Shilin Yang, Bing Yao, Yunfeng Zhou, Huiyong Yin, Ming-Zhi Zhang, Raymond C Harri. Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury. American journal of physiology. Renal physiology. vol 302. issue 6. 2012-05-09. PMID:22169008. |
in aromatic l-amino acid decarboxylase knockout (aadc ko) mice, a model of intrarenal dopamine deficiency due to selective proximal tubule aadc deletion, which inhibits intrarenal dopamine synthesis, ang ii infusion further increased expression of p-src and ptyr845-egfr. |
2012-05-09 |
2023-08-12 |
mouse |
| Shilin Yang, Bing Yao, Yunfeng Zhou, Huiyong Yin, Ming-Zhi Zhang, Raymond C Harri. Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury. American journal of physiology. Renal physiology. vol 302. issue 6. 2012-05-09. PMID:22169008. |
these results demonstrate a role for intrarenal dopamine to buffer the detrimental effects of ang ii upon the kidney. |
2012-05-09 |
2023-08-12 |
mouse |
| Maria Constanza Paz, Maria Amparo Assis, Ricardo J Cabrera, Liliana M Cancela, Claudia Bregonzi. The AT₁ angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol. Synapse (New York, N.Y.). vol 65. issue 6. 2012-03-12. PMID:20936684. |
angiotensin (ang) ii receptors are found on the soma and terminals of mesolimbic dopaminergic neurons and it has been shown that ang ii acting through its at₁ receptors facilitates dopamine release. |
2012-03-12 |
2023-08-12 |
rat |
| Birgit Mertens, Mustafa Varcin, Yvette Michotte, Sophie Sarr. The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death. The European journal of neuroscience. vol 34. issue 7. 2012-02-10. PMID:21936877. |
in the present work, the effect of daily treatment of rats with the angiotensin ii (ang ii) type 1 (at(1) ) receptor antagonist candesartan (3 mg/kg per day, s.c.) initiated 7 days before the intrastriatal injection of 6-hydroxydopamine (6-ohda) was investigated by means of tyrosine hydroxylase-positive cell counts in the substantia nigra, and dopamine and 3,4-dihydroxyphenylacetic acid measurements in the striatum. |
2012-02-10 |
2023-08-12 |
rat |
| Ming-Zhi Zhang, Bing Yao, Suwan Wang, Xiaofeng Fan, Guanqing Wu, Haichun Yang, Huiyong Yin, Shilin Yang, Raymond C Harri. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. The Journal of clinical investigation. vol 121. issue 7. 2011-10-13. PMID:21701066. |
decreasing intrarenal dopamine subjects the kidney to unbuffered responses to ang ii and results in the development of hypertension and a dramatic decrease in longevity. |
2011-10-13 |
2023-08-12 |
mouse |
| Linan Zhang, Fang Guo, Huicai Guo, Haiyan Wang, Zhe Zhang, Xu Liu, Xiaolu Shi, Xiangbo Gou, Qian Su, Jian Yin, Yongli Wan. The paradox of dopamine and angiotensin II-mediated Na(+), K(+)-ATPase regulation in renal proximal tubules. Clinical and experimental hypertension (New York, N.Y. : 1993). vol 32. issue 7. 2011-02-04. PMID:21029011. |
accumulated studies reported that the natruretic dopamine (da) and the anti-natruretic angiotensin ii (ang ii) represent an important mechanism to regulate renal na(+) and water excretion through intracellular secondary messengers to inhibit or activate renal proximal tubule (pt) na(+), k(+)-atpase (nka). |
2011-02-04 |
2023-08-12 |
Not clear |
| Laura H R Leite, Alex G Rodrigues, Danusa D Soares, Umeko Marubayashi, Cândido C Coimbr. Central fatigue induced by losartan involves brain serotonin and dopamine content. Medicine and science in sports and exercise. vol 42. issue 8. 2010-11-12. PMID:20068491. |
to investigate the influence of angiotensin ii (ang ii) at1 receptors blockade on central fatigue induced by brain content of serotonin (5-ht) and dopamine (da) during exercise. |
2010-11-12 |
2023-08-12 |
Not clear |
| Marcelo R Choi, Brenda M Lee, Cecilia Medici, Alicia H Correa, Belisario E Fernánde. Effects of angiotensin II on renal dopamine metabolism: synthesis, release, catabolism and turnover. Nephron. Physiology. vol 115. issue 1. 2010-08-05. PMID:20389130. |
dopamine (da) uptake inhibition in the renal cortex, elicited by angiotensin ii (ang ii), is mediated by at(1) receptors and signals through the phospholipase c pathway and activation of protein kinase c and cam-kinase ii. |
2010-08-05 |
2023-08-12 |
Not clear |
| Jan J Braszk. (+)-UH 232, a partial agonist of the D3 dopamine receptors, attenuates cognitive effects of angiotensin IV and des-Phe(6)-angiotensin IV in rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 4. 2010-06-21. PMID:20042318. |
we have recently found that postsynaptic d3 dopamine (da) receptors appear not to participate in the memory enhancing effects of the angiotensin at4 receptor agonists angiotensin iv (ang iv) and des-phe(6)-ang iv. |
2010-06-21 |
2023-08-12 |
rat |
| Marcelo R Choi, Cecilia Medici, Mariela M Gironacci, Alicia H Correa, Belisario E Fernánde. Angiotensin II regulation of renal dopamine uptake and Na(+),K(+)-ATPase activity. Nephron. Physiology. vol 111. issue 4. 2009-04-30. PMID:19293600. |
angiotensin ii (ang ii) decreases dopamine (da) uptake in renal cortex activating at(1) receptors. |
2009-04-30 |
2023-08-12 |
Not clear |
| Jan J Braszk. Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 19. issue 2. 2009-04-10. PMID:18835699. |
in this study effect of l745,870, a selective d(4) dopamine (da) receptor blocker, on the pro-cognitive action of intracerebroventricularly (icv) injected angiotensin iv (ang iv) and des-phe(6)-ang iv was examined. |
2009-04-10 |
2023-08-12 |
rat |
| Robert C Speth, Vardan T Karamya. Brain angiotensin receptors and binding proteins. Naunyn-Schmiedeberg's archives of pharmacology. vol 377. issue 4-6. 2008-12-03. PMID:18172611. |
the possible functional significance of this novel non-at1, non-at2 binding site for angiotensin peptides as a mediator of non-traditional actions of ang ii in the brain, e.g., stimulation of dopamine release from the striatum, as a peptidase, or as a clearance receptor, and the importance of the state of the internal environment of the brain to its function is reviewed. |
2008-12-03 |
2023-08-12 |
Not clear |
| C M Leite, G J R Machado, R C M Dornelles, C R Franc. Actions of angiotensin II and dopamine in the medial preoptic area on prolactin secretion. Physiological research. vol 57. issue 1. 2008-10-22. PMID:17223721. |
dopamine (da) is known as a primary regulator of prolactin secretion (prl) and angiotensin ii (ang ii) has been recognized as one brain inhibitory factor of this secretion. |
2008-10-22 |
2023-08-12 |
rat |
| Jan J Braszko, Przemysław Wielgat, Anna Walesiu. Effect of D(3) dopamine receptors blockade on the cognitive effects of angiotensin IV in rats. Neuropeptides. vol 42. issue 3. 2008-09-19. PMID:18359517. |
our previous studies showed that d(1) and d(2) dopamine receptors are indispensable for the cognitive effects of angiotensin iv (ang iv) and its des-phe(6) derivative des-phe(6)-ang iv to occur. |
2008-09-19 |
2023-08-12 |
rat |
| Jan J Braszko, Przemysław Wielgat, Anna Walesiu. Effect of D(3) dopamine receptors blockade on the cognitive effects of angiotensin IV in rats. Neuropeptides. vol 42. issue 3. 2008-09-19. PMID:18359517. |
as most neuroleptics currently used in the treatment of schizophrenia have variable d(2)/d(3) dopaminolytic selectivity, in this study we searched for the role of the d(3) dopamine receptors in facilitating learning and improving memory actions of ang iv and des-phe(6)-ang iv in rats. |
2008-09-19 |
2023-08-12 |
rat |
| Jan J Braszko, Przemysław Wielgat, Anna Walesiu. Effect of D(3) dopamine receptors blockade on the cognitive effects of angiotensin IV in rats. Neuropeptides. vol 42. issue 3. 2008-09-19. PMID:18359517. |
in conclusion, this study points to the minor significance of the d(3) dopamine receptors in the cognitive effects of ang iv and to the interesting, though unexplained, inhibition by nafadotride of the des-phe(6)-ang iv effects. |
2008-09-19 |
2023-08-12 |
rat |
| Hewang Li, Ines Armando, Peiying Yu, Crisanto Escano, Susette C Mueller, Laureano Asico, Annabelle Pascua, Quansheng Lu, Xiaoyan Wang, Van Anthony M Villar, John E Jones, Zheng Wang, Ammasi Periasamy, Yuen-Sum Lau, Patricio Soares-da-Silva, Karen Creswell, Gaétan Guillemette, David R Sibley, Gilbert Eisner, John J Gildea, Robin A Felder, Pedro A Jos. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. The Journal of clinical investigation. vol 118. issue 6. 2008-07-10. PMID:18464932. |
dopamine 5 receptor mediates ang ii type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. |
2008-07-10 |
2023-08-12 |
mouse |
| Hewang Li, Ines Armando, Peiying Yu, Crisanto Escano, Susette C Mueller, Laureano Asico, Annabelle Pascua, Quansheng Lu, Xiaoyan Wang, Van Anthony M Villar, John E Jones, Zheng Wang, Ammasi Periasamy, Yuen-Sum Lau, Patricio Soares-da-Silva, Karen Creswell, Gaétan Guillemette, David R Sibley, Gilbert Eisner, John J Gildea, Robin A Felder, Pedro A Jos. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. The Journal of clinical investigation. vol 118. issue 6. 2008-07-10. PMID:18464932. |
hypertension is a multigenic disorder in which abnormal counterregulation between dopamine and ang ii plays a role. |
2008-07-10 |
2023-08-12 |
mouse |
| Hewang Li, Ines Armando, Peiying Yu, Crisanto Escano, Susette C Mueller, Laureano Asico, Annabelle Pascua, Quansheng Lu, Xiaoyan Wang, Van Anthony M Villar, John E Jones, Zheng Wang, Ammasi Periasamy, Yuen-Sum Lau, Patricio Soares-da-Silva, Karen Creswell, Gaétan Guillemette, David R Sibley, Gilbert Eisner, John J Gildea, Robin A Felder, Pedro A Jos. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. The Journal of clinical investigation. vol 118. issue 6. 2008-07-10. PMID:18464932. |
recent studies suggest that this counterregulation results, at least in part, from regulation of the expression of both the antihypertensive dopamine 5 receptor (d5r) and the prohypertensive ang ii type 1 receptor (at1r). |
2008-07-10 |
2023-08-12 |
mouse |